According to the study, 3,603 children younger than nine months were screened using HemoTypeSC to show the feasibility of adding newborn screening into existing primary health-care immunizations with rapid testing. This reinforces access to patients with sickle cell in poor communities, a shift from developed countries with better nutrition, bigger financial budgets, and infectious disease vaccines having prominent accessibility, according to the Fogarty International Center at the National Institutes of Health.
The integration of newborn screening into existing primary healthcare immunization programs is feasible and can rapidly be implemented with limited resources, according to a study led by professor Obiageli Nnodu, director of the Centre of Excellence for Sickle Cell Disease Research and Training at Nigeria’s University of Abuja. To realistically screen every newborn for sickle cell disease, Nnodu says a simple, reliable and affordable point-of-care rapid test will be deployed at immunization clinics, a place most newborns will visit soon after birth. One such example is the HemoTypeSC) from Silver Lake Research, a diagnostics firm based in southern California.
The various hematology departments of the three university hospital centers in Côte d'Ivoire recorded in 2014, 11,972 patients suffering from sickle cell anemia, including 8,572 in Yopougon, 3,000 in Cocody and 400 in Treichville, with an average of 600 new cases each year. Patrice Sékongo, country director of the European Institute for Cooperation and Development, called for mass screening and improved patient care thanks to a preventive system that is operational. In a presentation on the evolution of screening tools, Dr Yao Atimeré, a hematologist, presented the HemoTypeSC test, which can detect sickle cell anemia in ten minutes. A solution that comes to save lives.
Erik Serrao discusses the data from a recently-completed field validation trial in southeastern Uganda. In this collaboration with the Sickle Cell Association of Uganda, led by Ruth Nankanja, HemoTypeSC correctly identified the hemoglobin type of 1,000 out of 1,000 children screened.
Dr. Alayo Sopekan, National Desk Officer, Ministry of Health, said: “Nigeria has the highest burden of Sickle Cell Disease (SCD) in the world ahead of Democratic Republic of Congo and India.” He called for early diagnosis and treatment of the disease.
Video: Nigerian officials reveal how the country loses over 150,000 newborns to sickle cell disease every year. OakTV presents a report on the accuracy of HemoTypeSC™, a 10 minute investigational test kit.
Video: Professor Obiageli Nnodu, sickle cell disease expert from the University of Abuja, describes the current status of sickle cell disease in Nigeria and the results from early testing with HemoTypeSC™.